Skip to Content

DA-029 2 (Abilify MyCite 2 mg)

Generic Name: aripiprazole

Pill with imprint DA-029 2 is Green, Rectangle and has been identified as Abilify MyCite 2 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd.

Abilify MyCite is used in the treatment of bipolar disorder; depression; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify MyCite 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DA-029 2

Abilify mycite 2 mg DA-029 2

Abilify MyCite

Generic Name
aripiprazole
Imprint
DA-029 2
Strength
2 mg
Color
Green
Size
8.00 mm
Shape
Rectangle
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Otsuka Pharmaceutical Co., Ltd
National Drug Code (NDC)
59148-0029
Inactive Ingredients
corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, ferric oxide yellow, ferric oxide red, FD&C Blue No. 2, aluminum oxide, aluminum, magnesium, silicon, silicon dioxide, titanium, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.